Vincent Weisser

Vincent Weisser, Chief Product Officer at Molecule, a platform bridging decentralized science and research funding, shares insights on transforming healthcare. He discusses how decentralized science creates scalable, transparent medical research environments and why decentralized autonomous organizations (DAOs) could revolutionize funding. Vincent highlights the challenges and opportunities of democratizing intellectual property in research, emphasizing a collaborative marketplace approach that could ultimately expedite drug development and enhance healthcare outcomes.